← The Wire
RPRXNasdaq
Royalty Pharma plc
Pharmaceutical Preparations · X0 · CIK 1802768
Largest buyer of biopharmaceutical royalties, funding innovation by acquiring rights to future sales of therapies
⚡ Elevated coverage
$24.32B
Market cap
$57.09
Last close
+1.5%
1D
+6.6%
5D
2.5M
Volume
Price · last 39 sessions+13.7%
May 4L $50.20 · H $57.09Jun 29
138
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 10, 2026DEFA14ADEFA14AApr 11, 2025DEFA14ADEFA14AApr 10, 2025DEFA14AFORM DEFA14AMar 5, 2025DEFA14AFORM DEFA14AJan 17, 2025DEFA14AFORM DEFA14AJan 16, 2025DEFA14ADEFA14AJan 13, 2025DEFA14AFORM DEFA14AJan 10, 2025DEFA14ADEFA14AApr 25, 2024DEFA14ADEFA14AApr 27, 2023DEFA14ADEFA14AApr 28, 2022DEFA14ADEFA14AApr 29, 2021
Insider Activity
In the 90 days to Mar 23, 2026: 2 sold $25.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Coyne Terrance P.EVP & CFO | Sell | 32,916 | $45.53 | $1.5M |
| Mar 23, 2026 | Coyne Terrance P.EVP & CFO | Sell | 1,875 | $45.53 | $85K |
| Mar 2, 2026 | Coyne Terrance P.EVP & CFO | Sell | 22,487 | $46.67 | $1.0M |
| Mar 2, 2026 | Coyne Terrance P.EVP & CFO | Sell | 10,429 | $47.01 | $490K |
| Mar 2, 2026 | Coyne Terrance P.EVP & CFO | Sell | 1,292 | $46.67 | $60K |
| Mar 2, 2026 | Coyne Terrance P.EVP & CFO | Sell | 583 | $47.01 | $27K |
| Feb 23, 2026 | Coyne Terrance P.EVP & CFO | Sell | 32,916 | $45.32 | $1.5M |
| Feb 23, 2026 | Coyne Terrance P.EVP & CFO | Sell | 1,875 | $45.32 | $85K |
| Feb 4, 2026 | Coyne Terrance P.EVP & CFO | Sell | 19,076 | $43.29 | $826K |
| Feb 4, 2026 | Coyne Terrance P.EVP & CFO | Sell | 1,087 | $43.29 | $47K |
| Feb 3, 2026 | Coyne Terrance P.EVP & CFO | Sell | 108,759 | $42.84 | $4.7M |
| Feb 3, 2026 | Coyne Terrance P.EVP & CFO | Sell | 6,195 | $42.84 | $265K |
| Feb 2, 2026 | Coyne Terrance P.EVP & CFO | Sell | 102,581 | $42.08 | $4.3M |
| Feb 2, 2026 | Coyne Terrance P.EVP & CFO | Sell | 5,843 | $42.08 | $246K |
| Jan 30, 2026 | Urist MarshallEVP, Research & Investments | Sell | 20,000 | $41.09 | $822K |
| Jan 23, 2026 | Urist MarshallEVP, Research & Investments | Sell | 20,000 | $40.26 | $805K |
| Jan 20, 2026 | Coyne Terrance P.EVP & CFO | Sell | 65,832 | $39.35 | $2.6M |
| Jan 20, 2026 | Coyne Terrance P.EVP & CFO | Sell | 3,750 | $39.35 | $148K |
| Jan 16, 2026 | Urist MarshallEVP, Research & Investments | Sell | 20,000 | $39.52 | $790K |
| Jan 9, 2026 | Urist MarshallEVP, Research & Investments | Sell | 20,000 | $40.78 | $816K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance